News

November 20, 2018 | News & Notices Shimadzu and Austin Health Sign Mutual Assistance Agreement to
Develop an Advanced Database Solution for Cardiac Patients

 

October 2018, Shimadzu Corporation and Austin Health with its primary research associate Dr. Mark Horrigan, Director of Cardiac Catheterization Services has entered into a Mutual Assistance Agreement to develop an advanced solution to enhance clinical outcomes following “Interventional procedures”. Interventional procedures provide an alternative to conventional “open surgeries” utilizing minimally invasive techniques that treat vascular disease from inside the vessel, monitoring with X-ray imaging in a Catheterization Laboratory. The minimally invasive approach is usually preferred by patients because there is little discomfort and recovery times are short.

Shimadzu is an global corporation founded in 1875 which provides high technology products and solutions for several industries including Medical Imaging, Analytical and Measuring Instruments, Aircraft Equipment and Industrial Machinery. Shimadzu's medical imaging systems contribute to the advancement of medicine throughout the world, supporting early detection and treatment of many conditions.

Austin Health is a prestigious Australian teaching hospital providing public health services to a diverse catchment of almost 1.28 million people covering a metropolitan and rural area extending across the North-Eastern part of Melbourne. The largest sites are located in Heidelberg near the city of Melbourne. Austin Health operates 980 beds and delivers a broad range of healthcare services including trauma, acute care, oncology, preventative and primary health care services, ambulatory care, general and spinal rehabilitation, mental health and Level 6 Cardiovascular services. Austin Health it is an internationally recognized leader in clinical teaching and training, with a University of Melbourne Clinical School and affiliations with seven other universities. Its Department of Cardiology has two catheterization laboratories equipped with Shimadzu Corporation’s advanced cardiovascular X-ray imaging systems that support complex interventional treatments for patients with cardiovascular disease.

The incidence of cardiovascular disease is increasing globally. Interventional treatments are popular because of their minimally disruptive nature but physicians must be vigilant to minimize exposure to radiation and to radiocontrast media that are nephrotoxic. Through their new agreement, Shimadzu Corporation and Austin Health will collaborate to develop a new data management approach combining new and existing information systems to assist catheterization laboratory staff minimize radiation and radiocontrast exposure during procedures. We do believe that this collaboration will create a system that delivers continuous improvement in healthcare outcomes.